(Total Views: 421)
Posted On: 10/27/2018 5:48:23 PM
Post# of 15624
Re: truebeliever #13702
Your story is true for all sorts of small investors in small companies. As prices rise Institutions swoop in and purchase most of the shares. Small investors often get the greatest percentage gains, going from pennies to dollars, but Institutions get the greatest dollar gains, riding stocks from $5 to $10 to $100's and more.
As many here know, I've been in ImmunoGen practically since it became public. Today it's sitting near 52 week lows, but I still believe in the drug that's in Phase 3 Trial, as well as the new technology drugs that should have their first trial results reported at ASH. With just a little success, I believe it should be priced comparable to SGEN, a large multiple of today's market cap. I actually think that if SGEN doesn't gain another drug approval before IMGN does, it could exceed SGEN, but we're talking about 2020 or later.
Gary
As many here know, I've been in ImmunoGen practically since it became public. Today it's sitting near 52 week lows, but I still believe in the drug that's in Phase 3 Trial, as well as the new technology drugs that should have their first trial results reported at ASH. With just a little success, I believe it should be priced comparable to SGEN, a large multiple of today's market cap. I actually think that if SGEN doesn't gain another drug approval before IMGN does, it could exceed SGEN, but we're talking about 2020 or later.
Gary
(0)
(0)
